- 現金殖利率: 11.63%、總殖利率: 11.63%、5年平均現金配發率: 16.61%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 6.02 | 0 | 2.00 | 0 | 0.00 | 0 | 33.22 | 0 | 0.00 | 0 | 33.22 | 0 |
| 2024 (4) | -0.47 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2023 (3) | 0.67 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | -0.54 | -108.45 | -1180.0 | -0.44 | 60.0 | -414.29 | -0.54 | -108.96 | -1180.0 |
| 25Q4 (7) | 6.39 | 3650.0 | 2303.45 | -1.10 | -900.0 | -746.15 | 6.03 | 1775.0 | 1382.98 |
| 25Q3 (6) | -0.18 | 21.74 | -157.14 | -0.11 | -37.5 | -450.0 | -0.36 | -100.0 | -89.47 |
| 25Q2 (5) | -0.23 | -560.0 | -109.09 | -0.08 | -157.14 | -900.0 | -0.18 | -460.0 | -50.0 |
| 25Q1 (4) | 0.05 | 117.24 | 0.0 | 0.14 | 207.69 | 0.0 | 0.05 | 110.64 | 0.0 |
| 24Q4 (3) | -0.29 | -314.29 | 0.0 | -0.13 | -550.0 | 0.0 | -0.47 | -147.37 | 0.0 |
| 24Q3 (2) | -0.07 | 36.36 | 0.0 | -0.02 | -300.0 | 0.0 | -0.19 | -58.33 | 0.0 |
| 24Q2 (1) | -0.11 | 0.0 | 0.0 | 0.01 | 0.0 | 0.0 | -0.12 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 0.67 | 10.85 | -39.78 | 2.65 | -40.62 | 1.99 | N/A | - | ||
| 2026/3 | 0.6 | -16.75 | -42.78 | 1.98 | -40.9 | 1.98 | 2.92 | - | ||
| 2026/2 | 0.72 | 9.21 | -33.21 | 1.38 | -40.04 | 2.5 | 2.32 | -0.17 | -0.35 | - |
| 2026/1 | 0.66 | -40.8 | -46.06 | 0.66 | -46.06 | 2.76 | 2.1 | - | ||
| 2025/12 | 1.11 | 12.92 | -2.52 | 13.22 | 4.18 | 3.13 | 1.82 | - | ||
| 2025/11 | 0.99 | -3.84 | 5.21 | 12.1 | 4.85 | 3.02 | 1.89 | - | ||
| 2025/10 | 1.03 | 1.78 | 8.52 | 11.12 | 4.82 | 3.31 | 1.72 | -0.19 | -0.65 | - |
| 2025/9 | 1.01 | -21.02 | 2.89 | 10.09 | 4.45 | 3.47 | 1.7 | - | ||
| 2025/8 | 1.28 | 8.24 | 8.52 | 9.08 | 4.63 | 3.55 | 1.66 | - | ||
| 2025/7 | 1.18 | 8.3 | 3.31 | 7.8 | 4.02 | 3.35 | 1.76 | -0.02 | -0.26 | - |
| 2025/6 | 1.09 | 1.28 | -5.25 | 6.62 | 4.15 | 3.27 | 1.78 | -0.19 | -0.24 | - |
| 2025/5 | 1.08 | -2.63 | 12.41 | 5.53 | 6.23 | 3.23 | 1.8 | -0.07 | -0.05 | - |
| 2025/4 | 1.1 | 5.34 | 7.26 | 4.46 | 4.84 | 3.23 | 1.8 | - | ||
| 2025/3 | 1.05 | -2.83 | 6.27 | 3.35 | 4.06 | 3.35 | 1.72 | - | ||
| 2025/2 | 1.08 | -11.79 | -10.54 | 2.3 | 3.08 | 3.45 | 1.68 | 0.03 | 0.15 | - |
| 2025/1 | 1.22 | 6.97 | 19.09 | 1.22 | 19.09 | 3.31 | 1.75 | - | ||
| 2024/12 | 1.14 | 21.89 | 4.43 | 12.69 | -3.72 | 3.03 | 1.9 | - | ||
| 2024/11 | 0.94 | -0.82 | 4.21 | 11.54 | -4.46 | 2.87 | 2.01 | -0.18 | -0.35 | - |
| 2024/10 | 0.95 | -3.49 | -15.44 | 10.6 | -5.16 | 3.1 | 1.85 | 0.03 | -0.17 | - |
| 2024/9 | 0.98 | -16.69 | -8.4 | 9.66 | -4.02 | 3.3 | 1.74 | - | ||
| 2024/8 | 1.18 | 3.04 | -12.22 | 8.68 | -3.5 | 3.47 | 1.65 | 0.04 | -0.08 | - |
| 2024/7 | 1.14 | -0.67 | -15.81 | 7.5 | -1.97 | 3.25 | 1.77 | 0.0 | -0.12 | - |
| 2024/6 | 1.15 | 20.17 | 2.22 | 6.36 | 1.01 | 3.14 | 1.76 | 0.06 | -0.12 | - |
| 2024/5 | 0.96 | -7.09 | -2.29 | 5.21 | 0.74 | 2.97 | 1.85 | - | ||
| 2024/4 | 1.03 | 4.37 | -7.05 | 4.25 | 1.46 | 3.22 | 1.71 | -0.04 | -0.05 | - |
| 2024/3 | 0.99 | -18.2 | 10.57 | 3.22 | 4.52 | 3.22 | N/A | -0.07 | -0.01 | - |
| 2024/2 | 1.21 | 17.41 | 27.53 | 2.23 | 2.05 | 3.33 | N/A | 0.08 | 0.06 | - |
| 2024/1 | 1.03 | -6.18 | -17.32 | 1.03 | -17.32 | 3.02 | N/A | -0.02 | -0.02 | - |
| 2023/12 | 1.1 | 21.63 | 5.12 | 13.18 | 19.36 | 3.11 | N/A | 0.06 | 0.49 | - |
| 2023/11 | 0.9 | -19.53 | 2.28 | 12.08 | 20.84 | 3.09 | N/A | -0.17 | 0.43 | - |
| 2023/10 | 1.12 | 4.53 | 11.11 | 11.18 | 22.64 | 3.53 | N/A | -0.03 | 0.6 | - |
| 2023/9 | 1.07 | -20.17 | 12.77 | 10.06 | 24.07 | 3.77 | N/A | -0.06 | 0.63 | - |
| 2023/8 | 1.34 | -1.16 | 12.75 | 8.99 | 25.57 | 3.82 | N/A | 0.23 | 0.69 | - |
| 2023/7 | 1.36 | 20.6 | 21.56 | 7.65 | 28.12 | 3.46 | N/A | 0.26 | 0.46 | - |
| 2023/6 | 1.13 | 14.86 | 42.24 | 6.29 | 29.62 | 3.21 | N/A | 0.05 | 0.2 | - |
| 2023/5 | 0.98 | -11.61 | 44.93 | 5.17 | 27.17 | 2.98 | N/A | -0.06 | 0.15 | - |
| 2023/4 | 1.11 | 24.16 | 43.5 | 4.19 | 23.63 | 2.95 | N/A | 0.08 | 0.21 | - |
| 2023/3 | 0.89 | -5.66 | 2.25 | 3.08 | 17.76 | 3.08 | N/A | -0.1 | 0.13 | - |
| 2023/2 | 0.95 | -23.88 | -0.45 | 2.19 | 25.52 | 3.23 | N/A | -0.0 | 0.23 | - |
| 2023/1 | 1.24 | 19.3 | 56.64 | 1.24 | 56.64 | 3.17 | N/A | 0.23 | 0.23 | 去年受新型冠狀病毒肺炎疫情影響 |
| 2022/12 | 1.04 | 18.34 | 14.79 | 11.04 | 42.01 | 2.93 | N/A | 0.08 | -0.33 | - |
| 2022/11 | 0.88 | -12.58 | 8.98 | 10.0 | 45.6 | 2.84 | N/A | -0.11 | -0.41 | - |
| 2022/10 | 1.01 | 6.09 | 16.34 | 9.12 | 50.49 | 3.15 | N/A | 0.0 | -0.3 | 去年受新型冠狀病毒肺炎疫情影響 |
| 2022/9 | 0.95 | -20.18 | 46.97 | 8.11 | 56.18 | 3.25 | N/A | 0.13 | -0.3 | 去年因新型冠狀病毒肺炎疫情影響 |
| 2022/8 | 1.19 | 6.55 | 101.48 | 7.16 | 57.49 | 3.1 | N/A | 0.15 | -0.43 | 去年因新型冠狀病毒肺炎疫情影響 |
| 2022/7 | 1.12 | 41.11 | 313.34 | 5.97 | 50.93 | 2.58 | N/A | 0.06 | -0.58 | 去年因新型冠狀病毒肺炎疫情影響 |
| 2022/6 | 0.79 | 17.03 | 411.94 | 4.86 | 31.71 | 2.24 | N/A | -0.22 | -0.65 | 去年因新型冠狀病毒肺炎疫情影響 |
| 2022/5 | 0.68 | -12.48 | 55.67 | 4.06 | 15.08 | 2.32 | N/A | -0.23 | -0.43 | 去年因新型冠狀病毒肺炎疫情影響 |
| 2022/4 | 0.77 | -11.52 | 0.71 | 3.39 | 9.39 | 2.6 | N/A | -0.22 | -0.2 | - |
| 2022/3 | 0.87 | -8.16 | 19.51 | 2.62 | 12.24 | 2.62 | N/A | 0.02 | 0.02 | - |
| 2022/2 | 0.95 | 19.77 | 12.21 | 1.74 | 8.92 | 2.65 | N/A | 0.06 | 0.0 | - |
| 2022/1 | 0.79 | -12.56 | 5.23 | 0.79 | 5.23 | 2.51 | N/A | - | ||
| 2021/12 | 0.91 | 12.35 | 3.94 | 7.77 | -32.34 | 2.58 | N/A | - | ||
| 2021/11 | 0.81 | -6.68 | 19.1 | 6.87 | -35.33 | 2.32 | N/A | - | ||
| 2021/10 | 0.87 | 34.02 | -18.05 | 6.06 | -39.04 | 2.1 | N/A | - | ||
| 2021/9 | 0.65 | 9.41 | -23.48 | 5.19 | -41.54 | 1.51 | N/A | - | ||
| 2021/8 | 0.59 | 118.6 | -46.45 | 4.55 | -43.43 | 1.01 | N/A | - | ||
| 2021/7 | 0.27 | 74.78 | -74.99 | 3.96 | -42.96 | 0.86 | N/A | 因新型冠狀病毒肺炎疫情影響 | ||
| 2021/6 | 0.15 | -64.41 | -84.7 | 3.69 | -37.05 | 0.0 | N/A | 因新型冠狀病毒肺炎疫情影響 | ||
| 2021/5 | 0.43 | -43.37 | -50.98 | 3.53 | -27.11 | 0.0 | N/A | 因新型冠狀病毒肺炎疫情影響 |